Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,780 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

NCT05640102

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • South Alabama Medical Science Foundation Mitchell Cancer Institute Mobile, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Los Angeles Cancer Network (Lacn) Glendale, California, United States
View Trial Details
Recruiting

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

NCT07235384

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Veracity Clinical Research Woolloongabba, Queensland, Australia
  • Skin Health Institute Carlton, Victoria, Australia
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Shandong Provincial Dermatology Hospital Jinan, Shandong, China
View Trial Details
Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

NCT06980480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Infirmary Health - Diagnostic & Medical Clinic (DMC) Mobile, Alabama, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • University of Kansas Westwood, Kansas, United States
  • University of Maryland | Greenebaum Cancer Center Baltimore, Maryland, United States
View all 48 locations
View Trial Details
Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 18 locations
View Trial Details

Related conditions